Skip to main content
. 2024 Nov 6;17(11):1491. doi: 10.3390/ph17111491

Table 6.

Synthetic accessibility values for imatinib, LMQC01 and LMQC04 predicted via SwissADME and AMBIT-SA.

Compound Synthetic Accessibility Score
SwissADME AMBIT-SA
Imatinib 3.78 65.70
LMQC01 4.46 58.32
LMQC04 3.43 55.26